Article | July 22, 2025

The Hidden Healthcare Benefits That Home Trial Support Provides

GettyImages-1346651718-decentralized-doctor-patient-computer-remote

Home Trial Support (HTS) plays a transformative role in decentralized clinical trials (DCTs), extending far beyond reducing patient burden and improving retention. By bringing trial procedures directly into the patient’s home, HTS enhances safety, ensures protocol adherence, and alleviates pressure on overstretched trial sites and healthcare systems. MRN’s highly trained healthcare professionals (HCPs) follow strict protocols, including sterilization, PPE use, and no-visits while ill, providing safe, personalized care and treatment in the comfort of a patient’s home.

HTS also supports clinical sites by offloading routine and complex trial procedures, allowing site staff to focus on critical tasks and expand trial capacity. With expertise in protocol adherence, IMP handling, and real-time reporting, MRN’s HCPs act as an extension of the trial site. These hidden benefits—enhanced patient experience, reduced AE/SAE risk, and faster trial timelines—ultimately increase healthcare access and improve trial outcomes. To unlock the full potential of HTS, it must be integrated into trial design from the outset, ensuring optimized efficiency, compliance, and patient-centered care. Examine home HTS enhances both patient & caregiver safety and wellbeing, while alleviating pressures on sites and generating greater ROI for sponsors.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

MRN - Medical Research Network